Heartflow, Inc. (HTFL): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$58.63M

Year ended 2025-12-31

-$74.94M

Trailing 12 months to 2026-06-30

2023-12-31 EBITDA (USD) 2025-12-31

Period ended	EBITDA	Change YoY	Source filing
2025-12-31	-$58.63M	n/m	2026-03-18, From 2025-01-01
2024-12-31	-$55.86M	n/m	2026-03-18, From 2024-01-01
2023-12-31	-$68.17M	n/a	2026-03-18, From 2023-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EBITDA	Change YoY
Heartflow, Inc. (HTFL)	2025-12-31	-$58.63M	n/m
SI-BONE, Inc. (SIBN)	2025-12-31	-$16.56M	n/m
Neuronetics, Inc. (STIM)	2025-12-31	-$27.97M	n/m
Treace Medical Concepts, Inc. (TMCI)	2025-12-31	-$43.53M	n/m
InfuSystem Holdings, Inc (INFU)	2025-12-31	$25.21M	+30.0%
Xtant Medical Holdings, Inc. (XTNT)	2025-12-31	$12.51M	n/m
Cerus Corp (CERS)	2025-12-31	-$7.25M	n/m
Orthopediatrics Corp (KIDS)	2025-12-31	-$18.12M	n/m
Lemaitre Vascular Inc (LMAT)	2025-12-31	$78.33M	+26.6%

Compare HTFL, SIBN, STIM, TMCI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗